The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Accenture trades at a steep discount, with shares over 35% below intrinsic value based on conservative free cash flow growth assumptions. Despite GenAI risks, ACN's wide economic moat, brand strength, and leading AI consulting position support confidence in long-term adaptability and resilience. Q1/26 results showed 5.9% revenue growth and a 120% YoY increase in AI revenues, though operating income and EPS declined modestly and free cash flow guidance was trimmed.
Accenture holds $9.6 billion in cash against $8.2 billion in total debt, reflecting a strong liquidity position. This balance sheet strength positions ACN well for strategic investments or navigating macroeconomic uncertainty. Trailing 8.75% free cash flow and 3.0% dividend yields are far better than other blue-chips available for investment.
The latest trading day saw Accenture (ACN) settling at $205.93, representing a -1.34% change from its previous close.
The March 2026 Top 15 dividend growth stocks list targets high-quality, undervalued companies with a projected 21.28% long-term CAGR and 1.13% average yield. Pure Quality and Value-focused stock selection strategies outperformed the original blended approach in February, though all variants posted negative returns for the month. Since inception, the watch list has underperformed SPY and VIG, with an 8.82% annualized return versus 14.59% and 12.34% respectively, but surfaced several high-return opportunities.
My watchlist aims to surface high-quality, attractively valued dividend stocks with the potential for double-digit total returns over 3–5 years. The original process blends quality and value, while pure quality and value variants offer unique selections and distinct performance profiles. Despite recent underperformance versus VYM, the watchlist maintains a 14.43% CAGR since inception, comfortably above the 12% target and with a higher starting yield.
Accenture (ACN) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
Accenture is significantly undervalued, trading at a 30-40% discount to peers, despite strong fundamentals and business resilience. Q1 results beat revenue and EPS expectations, with robust demand, record backlog, and margin expansion supporting a continued positive outlook. I maintain a Buy rating with a $257.5 target price, reflecting a 28% upside, supported by a conservative DCF and comparative multiples analysis.
Accenture (ACN) stock has decreased by 6.6% over the last day and is presently valued at $201.18, likely reflecting near-term concerns around enterprise IT spending and softer discretionary consulting budgets. However, the pullback comes after a period of relative resilience compared to other global IT services players, and may present a more compelling entry point for long-term investors.
Recently, Zacks.com users have been paying close attention to Accenture (ACN). This makes it worthwhile to examine what the stock has in store.
Accenture (ACN) stock has decreased by 24.6% in under a month, dropping from $285.09 on January 22, 2026, to $214.95 currently. Is this dip worth buying?